NHS leaders have warned that the costs of supporting people with ADHD and autism are becoming “out of control,” adding fresh pressure to a system already struggling with demand, staffing and access to care. The warning comes amid growing concern that services across England are being pulled in too many directions at once, with rising referrals, long waits and uneven support making it harder to plan care consistently.
Growing pressure on assessment and support services
The issue is not limited to diagnosis alone. In many parts of the health service, patients who seek assessment for ADHD or autism also need follow-up support, educational adjustments, mental health input or social care coordination. When those systems are stretched, the cost pressure does not fall on one department alone. It spreads across primary care, specialist services and local authority budgets, creating a wider strain on the NHS.
The BMJ reported on September 1, 2026 that NHS leaders raised the alarm over the scale of these costs, reflecting a broader debate about how services should respond to increasing demand without compromising quality or fairness. The concern is especially acute in England, where families often report lengthy waits and uncertainty about what help will be available after assessment.
Why the debate has intensified
The warning lands at a time when the NHS is facing multiple competing priorities, including workforce shortages, pressure on mental health care and ongoing concerns about the ability of services to meet demand. As more people seek help for neurodevelopmental conditions, commissioners are being asked to balance access, clinical need and affordability while avoiding delays that can worsen outcomes for children, young people and adults.
Recent BMJ coverage also shows that the wider health system is under close scrutiny, from staff shortages to service redesign and questions about who will provide care when demand rises. In that context, the debate over ADHD and autism costs is likely to shape discussions about how the NHS allocates resources in the months ahead.
What it means for patients and families
For patients, the immediate concern is whether rising costs could translate into tighter thresholds, longer waits or more variation in access depending on where they live. For families already navigating assessment pathways, any slowdown can add stress and uncertainty, especially when support in schools, workplaces or the community depends on a timely diagnosis.
Health leaders are now being pushed to find a model that is clinically robust and financially sustainable. That may involve better coordination between services, clearer eligibility rules and improved early support to reduce the need for more expensive crisis intervention later on. What is clear is that the debate is no longer just about diagnosis; it is about the future shape and affordability of neurodevelopmental care across the NHS.
Photo source: AI-generated or edited image
